Research Journals
1.
Pariary, R., Shome, G., Kalita, S., Kalita, S., Roy, A., Harikishore, A., Jana, K., Senapati, D., Mandal, B., Mandal, A. K. and Bhunia, A. (2024) Peptide based strategies: Combating Alzheimer's Amyloid Beta aggregation through ergomic design and fibril disruption. Biochemistry, 63, 2397-2413
2.
Alom, S. E., Kalita, S., Kawa, A. H., Mandal, B. and Swaminathan, R., (2024) Early events during the aggregation of Amyloid Beta (16-22) derived switch-peptides tracked using protein charge transfer spectra. Analytica Chimica Acta, 1297, 342374.
Kalita, S., Kalita, S., (2024) Self-Assembled Peptide Nanomaterials: A Mechanistic Approach and their Applications, The Chemical Axis, 23, (1), 7-12, ISSN: 2249-8842.
3.
Kalita, S., Kalita, S., Kawa, A. H., Shill, S., Gupta, A., Kumar, S. and Mandal, B. (2022) Copper Chelating Cyclic Peptidomimetic Inhibits Amyloid beta Fibrillogenesis. RSC Med. Chem., 13, 761-774.
4.
Kalita, S., Kalita, S., Paul, A., Shah, M., Kumar, S. and Mandal, B., (2021) Site-specific single point mutation by anthranilic acid in hIAPP8-37 enhances anti-amyloidogenic activity. RSC Chem. Biol., 2, 266-273.
Paul, A., Kumar, S., Kalita, S., Kalita, S., Sarkar, D., Bhunia, A., Bandyopadhyay, A., Mondal, A. C. and Mandal, B. (2021) An explicitly designed paratope of amyloid-beta prevents neuronal apoptosis in vitro and hippocampal damage in rat brain. Chem. Sci., 12, 2853-2862.
5.
Kalita, S., Kalita, S., Paul, A., Sarkar, A. and Mandal, B.; (2020) Peptidomimetics prepared by tail to side chain one component peptide stapling inhibit Alzheimer's amyloid-β fibrillogenesis. Chem. Sci., 11, 4171-4179.
6.
Ratha, B. N., Kar, R. K., Kalita, S., Kalita, S., Raha, S., Singha, A., Garai, K., Mandal, B. and Bhunia, A.; (2019) Sequence specificity of amylin-insulin interaction: a fragment-based insulin fibrillation inhibition study. BBA-Proteins and Proteomics, 1867, 405-415.
7.
Paul, A., Kumar, S., Kalita, S., Ghosh, A. K., Mondal, A. C. and Mandal, B.; (2018) A Peptide-Based Pro-drug Disrupts Alzheimer's Amyloid into Non-toxic species and reduces Aβ induced toxicity in vitro. Int J Pept Res Ther, 24 (1), 201-211.
8.
Kumar, S., Paul, A., Kalita, S., Kumar, A., Hazra, S., Ghosh, A. K., Mandal, B. and Mondal, A. C.; (2017) A peptide-based pro-drug ameliorates Amyloid-β induced neuronal apoptosis in vitro SH-SY5Y cells. Current Alzheimer Research. 14 (12) 1293.
Kumar, S., Paul, A., Kalita, S., Ghosh, A. K., Mandal, B. and Mondal, A.C.; (2017) Protective effects of β-sheet breaker α/β-hybrid peptide against amyloid β-induced neuronal apoptosis in vitro. Chem Biol Drug Des; 89 (6), 888-900.
Paul, A., Kalita, S., Kalita, S., Sukumar, P. and Mandal, B.; (2017) Disaggregation of Amylin Aggregate by Novel Conformationally Restricted Aminobenzoic Acid containing α/β and α/γ Hybrid Peptidomimetics. Sci. Rep., 7, 40095.
9.
Sharma, B., Kalita, S., Paul, A., Mandal, B. and Paul, S.; (2016) The role of caffeine as an inhibitor in the aggregation of amyloid-forming peptides: a unified molecular dynamics simulation and experimental study. RSC Adv., 6, 78548.
10.
Saha, A., Nadimpally, K.C., Paul, A., Kalita, S. and Mandal, B.; (2014) Phenolic Ester mediated oligopeptide synthesis promoted by HOBt. Protein and Peptide Letters, 21 (2) 188.
Seminar
1.
1. Kalita, S. and Mandal, B.; (2024) Restriction of amylin aggregation using side chain-to-tail stapled peptides: A therapeutic study to prevent type II diabetes. ICETB 2024, 11th-13th March, 2024, Nalbari College, Nalbari, Assam, OP32 (Oral Presentation).
2.
1. Kalita, S., Kalita, S. and Mandal, B.; (2020) Effective modulation against amyloid aggregation of hIAPP using modified stapled peptides. SSD 2020, 25th-26th September, 2020, B. Borooah College, Assam, India, PP16. (Poster presentation)
3.
1. Kalita, S., Kalita, S., Paul, A. and Mandal, B.; (2019) Inhibition of amylin aggregation by single point mutant of hIAPP at different positions. IPS 2019 28th February&1st March, 2019, BITS Pilani, Hyderabad Campus, India, P41. (Poster presentation).
2. Kalita, S., Kalita, S., Paul, A. and Mandal, B.; (2019) Inhibition of toxic diabetic's amyloid aggregation by conformationally restricted hybrid Peptidomimetics. SSD 2019, 9th January, 2019, B. Borooah College, Assam, India, OP40, page 55. (Oral presentation)
4.
1. Kalita, S., Paul, A., Kalita, S., and Mandal, B.; (2017) Disaggregation of amylin aggregation by novel conformationally restricted aminobenzoic acid containing α/β and α/γ hybrid Peptidomimetics. ICSIMR 2017, 30th June-1st July, 2017, IIT Guwahati, India, PP61, page 122. (Participation).
2. Kalita, S., Paul, A., Kalita, S. and Mandal, B.; (2017) A novel strategy for drug design against Diabetes Type II (T2D) by disaggregation of amylin aggregation by conformationally restricted hybrid Peptidomimetics. Chem Convene 2017, 25th July, 2017, IIT Guwahati, India, P40, page 84. (Poster presentation, recipient of best poster presentation award).
5.
1. Kalita, S., Paul, A., Kalita, S. and Mandal, B.; (2016) Anti-diabetic activity of aminobenzoic acid containing α/β and α/γ but not α/δ hybrid peptide. FICS 2016, 8th -10th December 2016, IIT Guwahati, India, OP13, page 50. (Oral presentation)
Workshop
1.
1. National Workshop on Advanced Probing Techniques in TEM (APTTEM-2016) at IIT Guwahati, Assam, India, 15th-16th February, 2016.
